JSJerome Franklin Sah

Jerome Franklin Sah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jerome Franklin Sah has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Ellen A. Rorke

    2 shared publications
  • James K. V. Willson

    Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390

    2 shared publications
  • Richard L. Eckert

    2 shared publications
  • Sanford D. Markowitz

    Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

    2 shared publications
  • Anthony Shuber

    1 shared publication
  • Bala Krishna Kolli

    From the ‡Departments of Microbiology and Immunology and ¶Neuroscience, University of Health Sciences, Chicago Medical School, North Chicago, Illinois 60064 and ‖The Rockefeller University, New York, New York 10021

    1 shared publication

Latest Publications

  • The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers

    by Chunguang Guo, Jerome F. Sah, Lydia Beard, James K. V. Willson, Sanford D. Markowitz, Kishore Guda

    MicroRNAs (miRNA/miR) are a class of small noncoding RNAs implicated in the pathogenesis of various malignancies. In the current study, using micro(RNA) arrays, we found a ubiquitous loss of miR‐126 expression in colon cancer lines when compared to normal human colon epithelia. Reconstitution of miR‐126 in colon cancer cells resulted in a significant growth reduction as evidenced in clonogenic assays. A search for miR‐126 gene targets revealed p85β, a regulatory subunit involved in stabilizing and propagating the phosphatidylinositol 3‐kinase (PI3K) signal, as one of the potential substrates. Restoration of miR‐126 in cancer cells induced a ≥3‐fold reduction in p85β protein levels, with no concomitant change in p85α, a gene that is functionally related to p85β but not a supposed target of miR‐126. Additionally, using reporter constructs, we show that the p85β‐3′ untranslated region is directly targeted by miR‐126. Furthermore, this miR‐126 mediated reduction of p85β was accompanied by a substantial reduction in phosphorylated AKT levels in the cancer cells, suggesting an impairment in PI3K signaling. Finally, in a panel of matched normal colon and primary colon tumors, each of the tumors demonstrated miR‐126 down‐regulation together with an increase in the p85β protein level. Taken together, we propose that miR‐126 regulates PI3K signaling partly by targeting p85β, and that the loss of miR‐126 may provide a selective growth advantage during colon carcinogenesis.


  • Open Access

    Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

    by Wei-Dong Chen, Z. James Han, Joel Skoletsky, Jeff Olson, Jerome Sah, Lois Myeroff, Petra Platzer, Shilong Lu, Dawn Dawson, Joseph Willis, et al.

    Background: Increased DNA methylation is an epigenetic alteration that is common in human cancers and is often associated with transcriptional silencing. Aberrantly methylated DNA has also been proposed as a potential tumor marker. However, genes such as vimentin, which are transcriptionally silent in normal epithelium, have not until now been considered as targets for cancer-associated aberrant methylation and for use as cancer markers. Methods: We applied methylation-specific polymerase chain reaction to the vimentin gene, which is transcriptionally silent in normal colonocytes, and compared methylation of vimentin exon 1 in cancer tissues and in fecal DNA from colon cancer patients versus control samples from healthy subjects. Results: Vimentin exon-1 sequences were unmethylated in 45 of 46 normal colon tissues. In contrast, vimentin exon-1 sequences were methylated in 83% (38 of 46) and 53% (57 of 107) of tumors from two independently collected groups of colon cancer patients. When evaluated as a marker for colon cancer detection in fecal DNA from another set of colon cancer patients, aberrant vimentin methylation was detected in fecal DNA from 43 of 94 patients, for a sensitivity of 46% (95% confidence interval [CI] = 35% to 56%). The sensitivity for detecting stage I and II cancers was 43% (26 of 60 case patients) (95% CI = 31% to 57%). Only 10% (20 of 198 case patients) of control fecal DNA samples from cancer-free individuals tested positive for vimentin methylation, for a specificity of 90% (95% CI = 85% to 94%). Conclusions : Aberrant methylation of exon-1 sequences within the nontranscribed vimentin gene is a novel molecular biomarker of colon cancer and can be successfully detected in fecal DNA to identify nearly half of individuals with colon cancer.


  • Open Access

    The human tumour suppressor gene SLC5A8 expresses a Na+–monocarboxylate cotransporter

    by Michael J. Coady, Min‐Hwang Chang, Francois M. Charron, Consuelo Plata, Bernadette Wallendorff, Jerome Frank Sah, Sanford D. Markowitz, Michael F. Romero, Jean‐Yves Lapointe

    The orphan cotransport protein expressed by the SLC5A8 gene has been shown to play a role in controlling the growth of colon cancers, and the silencing of this gene is a common and early event in human colon neoplasia. We expressed this protein in Xenopus laevis oocytes and have found that it transports small monocarboxylic acids. The electrogenic activity of the cotransporter, which we have named SMCT (sodium monocarboxylate transporter), was dependent on external Na+ and was compatible with a 3 : 1 stoichiometry between Na+ and monocarboxylates. A portion of the SMCT‐mediated current was also Cl− dependent, but Cl− was not cotransported. SMCT transports a variety of monocarboxylates (similar to unrelated monocarboxylate transport proteins) and most transported monocarboxylates demonstrated Km values near 100 μm, apart from acetate and d‐lactate, for which the protein showed less affinity. SMCT was strongly inhibited by 1 mm probenecid or ibuprofen. In the absence of external substrate, a Na+‐independent leak current was also observed to pass through SMCT. SMCT activity was strongly inhibited after prolonged exposure to high external concentrations of monocarboxylates. The transport of monocarboxylates in anionic form was confirmed by the observation of a concomitant alkalinization of the cytosol. SMCT, being expressed in colon and kidney, represents a novel means by which Na+, short‐chain fatty acids and other monocarboxylates are transported in these tissues. The significance of a Na+–monocarboxylate transporter to colon cancer presumably stems from the transport of butyrate, which is well known for having anti‐proliferative and apoptosis‐inducing activity in colon epithelial cells.


  • Open Access

    Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling Pathway

    by Jerome F. Sah, Sivaprakasam Balasubramanian, Richard L. Eckert, Ellen A. Rorke


  • Open Access

    Genetic Rescue of Leishmania Deficiency in Porphyrin Biosynthesis Creates Mutants Suitable for Analysis of Cellular Events in Uroporphyria and for Photodynamic Therapy

    by Jerome Franklin Sah, Hiroya Ito, Bala Krishna Kolli, Daniel A. Peterson, Shigeru Sassa, Kwang-Poo Chang


  • Open Access

    Effects of ultraviolet‐B radiation on phycobilisomes of Synechococcus PCC 7942: Alterations in conformation and energy transfer characteristics

    by Jerome F. Sah, Kolli Bala Krishna, Madhulika Srivastava, Prasanna Mohanty

    Phycobilisomes (PBS), the major light harvesting antenna of the cyanobacterium Synechococcus contain phycocyanin (PC) and allophycocyanin (APC) as major pigment-protein complexes. PBS also absorb ultraviolet-B (280-320 nm) radiation. Exposure of Synechococcus PBS to low dose of UV-B (∼0.28 mw.cm-2) for 90 min induced change in absorption, emission and excitation characteristics of PBS and these changes got enhanced after 3 h of exposure. Room temperature excitation and emission spectra clearly indicated uncoupling of energy transfer from PC to APC on exposure to UV-B. Also, the 77K emission spectra suggested that F682 emission originating from APC decreased by 42% after 3 h of exposure. Circular dichroism (CD) spectra of UV-B exposed PBS indicated changes (14% decrease) in the α-helical content after 90 min treatment. SDS-PAGE analysis indicated degradation of a 75 kDa polypeptide (which appear to be a linker polypeptide) on UV-B treatment. The degradation of this polypeptide seems to induce changes in pigment-protein interaction and decoupling of energy transfer within the PBS. Our results for the first time clearly indicate that the PBS of Synechococcus are targets for UV-B damage.


    • 1 November 1993
      • Vol. 31  (4) , 755-67

    Purification and characterization of an ATPase inhibitor protein from buffalo mitochondria.

    by J F Sah, C Kumar, P Mohanty

    A heat stable, 12kDa protein was purified to homogeneity from buffalo heart mitochondria. It suppressed hydrolytic activity of membrane bound mitochondrial ATPase and its functional activity was Mg++ and ATP dependent. Maximal inhibition was achieved at slightly acidic pH. Its ability to inhibit ATP hydrolysis was significantly diminished at alkaline pH and high ionic strength and the purified protein had a tendency to aggregate under such conditions. Circular dichroism (CD) studies revealed that the protein undergoes reversible changes in secondary structure from a predominantly alpha-helical form at alkaline pH to a beta-sheet structure at slightly acidic pH. These distinctly different conformations could be correlated with functionally 'inactive' and 'active' forms.